What comes first: treatment of viral hepatitis or liver cancer?

JJ Feld, LAP Krassenburg - Digestive diseases and sciences, 2019 - Springer
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are the most important
underlying causes for the development of hepatocellular carcinoma (HCC) worldwide …

Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful

W Abdelhamed, M El‐Kassas - Journal of Viral Hepatitis, 2023 - Wiley Online Library
The occurrence of hepatocellular carcinoma (HCC) is one of the most serious complications
of hepatitis C virus (HCV) infection. Recently, effective antiviral medications have made …

Five-year follow-up of cured HCV patients under real-world interferon-free therapy

R Flisiak, D Zarębska-Michaluk, E Janczewska… - Cancers, 2021 - mdpi.com
Simple Summary Hepatitis C virus (HCV) is the major factor responsible for hepatocellular
carcinoma (HCC). Currently available treatments for HCV infection are short, simple …

Role of antiviral therapy in the management of hepatocellular carcinoma

YS Guan, Q He - Anti-cancer drugs, 2013 - journals.lww.com
Globally, hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection leads to liver
fibrosis and cirrhosis, which in turn causes resultant hepatocellular carcinoma (HCC) …

Hepatitis C antiviral therapy in patients with successfully treated hepatocellular carcinoma: dancing with wolves

M El Kassas, A Tawheed, M Eltabbakh… - Journal of …, 2019 - Taylor & Francis
Hepatitis C virus (HCV) infection is known to be one of the leading causes of hepatocellular
carcinoma (HCC) all over the world. Previously, multiple studies have confirmed a …

Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment

H Ikenaga, S Uchida‐Kobayashi… - Journal of Viral …, 2022 - Wiley Online Library
Hepatocellular carcinoma (HCC) has high recurrence rates. HCC sometimes progresses
from early‐stage HCC (Barcelona Clinic Liver Cancer [BCLC] stage 0/A) to advanced‐stage …

Treatment of hepatitis C virus infection in patients with hepatocellular carcinoma: Truth or dare?

T Mocan, I Nenu, R Crăciun… - … of Gastroenterology and …, 2021 - Wiley Online Library
The discovery of direct acting antivirals (DAA) with high rates of sustained virusological
response is the biggest epoch‐making event in the history of hepatitis C virus (HCV) …

Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response

T Kanda, S Matsuoka, M Moriyama - Hepatology International, 2018 - Springer
Chronic hepatitis C virus (HCV) infection is one of the major causes of liver cirrhosis and
hepatocellular carcinoma (HCC). Recently, the interferon-free combination of direct-acting …

Bridging basic science and clinical research–the EASL monothematic conference on translational research in viral hepatitis

T Boettler, D Moradpour, R Thimme, F Zoulim - Journal of hepatology, 2014 - Elsevier
Summary The EASL Monothematic Conference on Translational Research in Viral Hepatitis
brought together a group of leading scientists and clinicians working on both, basic and …

Direct-acting antiviral therapy for hepatitis C virus in patients with BCLC stage B/C hepatocellular carcinoma

SW Lee, LS Chen, SS Yang, YH Huang, TY Lee - Viruses, 2022 - mdpi.com
Background: The benefits of hepatitis C virus (HCV) eradication for hepatocellular
carcinoma (HCC) patients in Barcelona Clinic Liver Cancer (BCLC) stage B/C remain …